Altered expression of circulating microRNA in plasma of patients with primary osteoarthritis and in silico analysis of their pathways

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Borgonio Cuadra, Verónica M ^a   González Huerta, Norma Celia ^a   Romero Córdoba, Sandra ^b   Hidalgo Miranda, Alfredo ^b   Miranda Duarte, Antonio ^a  

^a INSTITUTO NACIONAL DE REHABILITACIÓN   (Mexico)

^b INSTITUTO NACIONAL DE MEDICINA GENÓMICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; FIBROBLAST GROWTH FACTOR RECEPTOR 1; INTERLEUKIN 1BETA; MESSENGER RNA; MICRORNA; MICRORNA 126; MICRORNA 146A; MICRORNA 16; MICRORNA 184; MICRORNA 186; MICRORNA 195; MICRORNA 20B; MICRORNA 29C; MICRORNA 30B; MICRORNA 345; MICRORNA 885 5P; MICRORNA 93; NERVE GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; PROCOLLAGEN C PROTEINASE; PROTEIN KINASE B; SMAD1 PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CARTILAGE CELL; CARTILAGE INJURY; COL3A GENE; COLLAGEN SYNTHESIS; COMPUTER ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FIBROBLAST GROWTH FACTOR RECEPTOR 1 GENE; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC VARIABILITY; HUMAN; INTERLEUKIN 1BETA GENE; KNEE OSTEOARTHRITIS; MALE; METABOLISM; MRNA EXPRESSION ASSAY; PAIN; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; RNA ANALYSIS; SIGNAL TRANSDUCTION; SMAD1 GENE; TISSUE DIFFERENTIATION; UPREGULATION; VASCULOTROPIN GENE; CASE CONTROL STUDY; CLUSTER ANALYSIS; GENETICS; MIDDLE AGED; OSTEOARTHRITIS; REPRODUCIBILITY; RNA INTERFERENCE; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MALE; MICRORNAS; MIDDLE AGED; OSTEOARTHRITIS; REPRODUCIBILITY OF RESULTS; RNA INTERFERENCE; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION;

EID: 84902477581     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097690     Document Type: Article

References (45)

1. Felson DT (2009) Developments in the clinical understanding of osteoarthritis. Arthritis Res Ther 11: 203-13.
2. Michael JW, Schlüter-Brust KU, Eysel P (2010) The epidemiology, etiology, diagnosis, and treatment of osteoarthritis of the knee. Dtsch Arztebl Int 107: 152-62.
3. Li X, Wu JF (2010) Recent developments in patent anti-cancer agents targeting the matrix metalloproteinases (MMPs). Recent Pat Anticancer Drug Discov 2010; 5: 109-41.
4. Little CB, Barai A, Burkhardt D, Smith SM, Fosang AJ, et al. (2009) Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development. Arthritis Rheum 60: 3723-33.
5. Gooljarsingh LT, Lakdawala A, Coppo F, Luo L, Fields GB, et al. (2008) Characterization of an exosite binding inhibitor of matrix metalloproteinase 13. Prot Sci 17: 66-71.
6. Gilbert AM, Bursavich MG, Lombardi S, Georgiadis KE, Reifenberg E, et al. (2009) N-(8-Hydroxy-5-substituted-quinolin-7-yl) (phenyl)methyl)-2-phenyloxy/ amino-acetamide inhibitors of ADAMTS-5 (Aggrecanase-2). Bioorg Med Chem Lett 18: 6454-57.
7. Wittwer AJ, Hills RL, Keith RH, Munie GE, Arner EC, et al. (2007) Substrate dependent inhibition kinetics of an active site directed inhibitor of ADAMTS-4 (Aggrecanase 1). Biochemistry 46: 6393-401. (Pubitemid 46842882)
8. Tortorella MD, Tomasselli AG, Mathis KJ, Schnute ME, Woodard SS, et al. (2009) Structural and inhibition analysis reveals the mechanism of selectivity of a series of aggrecanase inhibitors. J Biol Chem 284: 24185-91.
9. Goldring MB, Goldring SR (2010) Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Ann N Y Acad Sci 1192: 230-7.
10. Chapman K, Valdes AM (2012) Genetic factors in OA pathogenesis. Bone 5: 258-64.
11. Yang N, Coukos G, Zhang L (2008) MicroRNA epigenetic alterations in human cancer: one step forward in diagnosis and treatment. Int J Cancer 122(5): 963-8. (Pubitemid 351213992)
12. Lee Y, Ahn C, Han J, Choi H, Kim J, et al. (2003) The nuclear RNase III Drosha initiates microRNA processing. Nature 425: 415-9. (Pubitemid 37187272)
13. Lee Y, Jeon K, Lee JT, Kim S, Kim VN (2002) MicroRNA maturation: stepwise processing and subcellular localization. EMBO J 21: 4663-70. (Pubitemid 34984353)
14. Pillai RS, Bhattacharyya SN, Filipowicz W (2007) Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol 17: 118-26. (Pubitemid 46357525)
15. Bartel D (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-97.
16. Griffiths-Jones S (2004) The microRNA Registry. Nucleic Acids Res 32: 109-11.
17. Kim VN, Nam JW (2006) Genomics of microRNA. Trends Genet 22: 165-73. (Pubitemid 43290020)
18. Zamore PD, Haley B (2005) Ribo-genome: the big world of small RNAs. Science 309: 1519-24. (Pubitemid 41266468)
19. Cheng AM, Byrom MW, Shelton J, Ford LP (2005) Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 33: 1290-7. (Pubitemid 41439922)
20. Liang Y, Ridzon D, Wong L, Chen C (2007) Characterization of micro-RNA expression profiles in normal human tissues. BMC Genomics 8: 166.
21. Iuliano R, Vismara MF, Dattilo V, Trapasso F, Baudi F, et al. (2013) The role of microRNAs in cancer susceptibility. Biomed Res Int doi/10.1155/2013/ 591931.
22. Kobayashi T, Lu J, Cobb BS, Rodda SJ, McMahon AP, et al. (2008) Dicerdependent pathways regulate chondrocyte proliferation and differentiation. Proc Natl Acad Sci USA 105(6): 1949-54. (Pubitemid 351439445)
23. Iliopoulos D, Malizos KN, Oikonomou P, Tsezou A (2008) Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks. (Abstract). PLOS One 3: e3740.
24. Jones SW, Watkins G, Le Good N, Roberts S, Murphy CL, et al. (2009) The identification of differentially expressed microRNA in osteoarthritic tissue that modulate the production of TNF-alpha and MMP13. Osteoarthritis Cartilage 17: 464-72.
25. Akhtar N, Rasheed Z, Ramamurthy S, Anbazhagan AN, Voss FR, et al. (2010) MicroRNA-27b regulates the expression of matrix metalloproteinase 13 in human osteoarthritis chondrocytes. Arthritis Rheum; 62(5): 1361-71.
26. Miyaki S, Sato T, Inoue A, Otsuki S, Ito Y, et al. (2010) MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev 24: 1173-85.
27. Yamasaki K, Nakasa T, Miyaki S, Ishikawa M, Deie M, et al. (2009) Expression of microRNA-146a in osteoarthritis cartilage. Arthritis Rheum 60: 1035-41.
28. Murata K, Yoshitomi H, Tanida S, Ishikawa M, Nishitani K, et al. (2010) Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis. (Abstract). Arthritis Res Ther 12: R86.
29. Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16: 494-502.
30. Kroh EM, Parkin RK, Mitchell PS, Tewari M (2010) Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 50(4): 298-301.
31. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative CT method. Nat Protoc 3: 1101-8. (Pubitemid 351818697)
32. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-Delta Delta CT method. Methods 25: 402-8. (Pubitemid 34164012)
33. Tomaselli S, Panera N, Gallo A, Alisi A (2012) Circulating miRNA profiling to identify biomarkers of dysmetabolism. Biomark Med 6(6): 729-42.
34. Sapre N, Selth LA (2013) Circulating microRNAs as biomarkers of prostate cancer: The state of play. Prostate Cancer. Published online 2013: 539680. doi:10.1155/2013/539680.
35. Tang D, Shen Y, Wang M, Yang R, Wang Z, et al. (2013) Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer. Eur J Cancer Prev (Epub ahead of print).
36. Díaz-Prado S, Cicione C, Muiños-López E, Hermida-Gómez T, Oreiro N, et al. (2012) Characterization of microRNA expression profiles in normal and osteoarthritic human chondrocytes. BMC Musculoskelet Disord 13: 144.
37. Nakasa T, Miyaki S, Okubo A, Hashimoto M, Nishida K, et al. (2008) Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum 58(5): 1284-92. (Pubitemid 351705917)
38. Montecalvo A, Larregina AT, Shufesky WJ, Stolz DB, Sullivan ML, et al. (2012) Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood 119: 756-66.
39. Li J, Huang J, Dai L, Yu D, Chen Q, et al. (2012) miR-146a, an IL-1β responsive miRNA, induces vascular endothelial growth factor and chondrocyte apoptosis by targeting Smad4. (Abstracty. Arthritis Res Ther 16; 14(2): R75.
40. Chamorro-Jorganes A, Araldi E, Penalva LO, Sandhu D, Fernández- Hernando C, et al. (2011) MicroRNA-16 and microRNA-424 regulate cell-autonomous angiogenic functions in endothelial cells via targeting vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1. Arterioscler Thromb Vasc Biol 31(11): 2595-606.
41. Caporali A, Emanueli C (2011) MicroRNA-503 and the extended microRNA-16 family in angiogenesis. Trends Cardiovasc Med 21(6): 162-6.
42. Liu G, Keeler BE, Zhukareva V, Houlé JD (2010) Cycling exercise affects the expression of apoptosis-associated microRNAs after spinal cord injury in rats. Exp Neurol 226(1): 200-6.
43. Zamli Z, Sharif M (2011) Chondrocyte apoptosis: a cause or consequence of osteoarthritis? Int J Rheum Dis 14(2): 159-66.
44. Wang B, Komers R, Carew R, Winbanks CE, Xu B, et al. (2012) Suppression of microRNA-29 expression by TGF-b1 promotes collagen expression and renal fibrosis. J Am Soc Nephrol 23(2): 252-65.
45. Miyaki S, Asahara H (2012) Macro view of microRNA function in osteoarthritis. Nat Rev Rheumatol 8(9): 543-52.